🇺🇸 FDA
Pipeline program

Newnorm

NORM-01

Phase 3 small_molecule active

Quick answer

Newnorm for Human Normal Immunoglobulin is a Phase 3 program (small_molecule) at Maze Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Maze Therapeutics
Indication
Human Normal Immunoglobulin
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials